Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec 31;16(12):8831-8835.
doi: 10.21037/jtd-24-1537. Epub 2024 Dec 28.

Revealing age and gender as determinants of survival after pulmonary segmentectomy should represent just the beginning of more discovery

James W Antonios  1 , Anthony W Kim  2
Affiliations
Editorial

Revealing age and gender as determinants of survival after pulmonary segmentectomy should represent just the beginning of more discovery

James W Antonios et al. J Thorac Dis. .
No abstract available

Keywords: Segmentectomy; age; gender; lobectomy; non-small cell lung cancer (NSCLC).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-1537/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607-17. 10.1016/S0140-6736(21)02333-3 - DOI - PubMed
    1. Hattori A, Suzuki K, Takamochi K, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial. Lancet Respir Med 2024;12:105-16. 10.1016/S2213-2600(23)00382-X - DOI - PubMed
    1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22; discussion 622-3. 10.1016/0003-4975(95)00537-u - DOI - PubMed
    1. Altorki N, Wang X, Kozono D, et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med 2023;388:489-98. 10.1056/NEJMoa2212083 - DOI - PMC - PubMed
    1. Mathey-Andrews C, Abruzzo AR, Venkateswaran S, et al. Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion. Ann Thorac Surg 2024;117:1007-14. 10.1016/j.athoracsur.2023.06.020 - DOI - PubMed

LinkOut - more resources